$0.0013
+0 (+0%)
At Close: Jun 23, 2026
MRES: Institute of Biomedical Research unveils artificial intelligence (AI) powered initiatives within its CBD product range, psilocybin research, and cardiometabolic health solutions
02:06pm, Wednesday, 07'th Jun 2023 InvestorsHub
MRES: Institute of Biomedical Research unveils artificial intelligence (AI) powered initiatives within its CBD product range, psilocybin research, and cardiometabolic health solutions
CAPE TOWN, SOUTH AFRICA -- June 7, 2023 -- InvestorsHub NewsWire -- Institute of Biomedical Research Corp. (OTC PINK: MRES) ("Institute of Biomedical Research" or the "Company"), a nutraceutical biotechnology company focused on alternative plant-based cannabinoids, medical...
M2Bio Appoints Ze-ev Krein as Chairman of the M2Bio Scientific Advisory Board
11:25am, Thursday, 06'th Apr 2023 InvestorsHub
CAPE TOWN, SOUTH AFRICA -- April 6, 2023 -- Institute of Biomedical Research (OTC PINK: MRES) ("M2Bio Sciences'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research is pleased to share the following update:
Ze-ev Krein has accepted the Chairman position for M2Bio’s Scientific Advisory Board. His experience in legislation, drug development, analytical chemistry, and computer science wi...
Sign In
Buy MRES